ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.702,27
0,11%
S&P 500
5.307,01
-0,27%
Dow Jones
39.671,04
-0,51%
Euro vs US Dollar
1,08413
0,15%
Bitcoin
69.646,58
0,79%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Nautilus Biotechnology Inc (NAUT)

  7. Nautilus Biotechnology Inc (NAUT) News

NAUT

Nautilus Biotechnology (NAUT)

Nautilus Biotechnology Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:NAUT
DatumZeitQuelleÜberschriftSymbolFirma
30/04/202414h00GlobeNewswire Inc.Nautilus Biotechnology Reports First Quarter 2024 Financial ResultsNASDAQ:NAUTNautilus Biotechnology Inc
11/04/202414h00GlobeNewswire Inc.Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024NASDAQ:NAUTNautilus Biotechnology Inc
07/03/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NAUTNautilus Biotechnology Inc
06/03/202422h39Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:NAUTNautilus Biotechnology Inc
05/03/202422h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAUTNautilus Biotechnology Inc
05/03/202422h46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAUTNautilus Biotechnology Inc
05/03/202422h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAUTNautilus Biotechnology Inc
05/03/202422h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAUTNautilus Biotechnology Inc
05/03/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAUTNautilus Biotechnology Inc
28/02/202414h00GlobeNewswire Inc.Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsNASDAQ:NAUTNautilus Biotechnology Inc
28/02/202413h26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAUTNautilus Biotechnology Inc
28/02/202413h25Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:NAUTNautilus Biotechnology Inc
28/02/202413h15Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NAUTNautilus Biotechnology Inc
28/02/202413h04Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NAUTNautilus Biotechnology Inc
28/02/202413h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAUTNautilus Biotechnology Inc
22/02/202414h00GlobeNewswire Inc.Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare ConferenceNASDAQ:NAUTNautilus Biotechnology Inc
07/02/202414h00GlobeNewswire Inc.Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024NASDAQ:NAUTNautilus Biotechnology Inc
14/12/202322h17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAUTNautilus Biotechnology Inc
30/11/202314h00GlobeNewswire Inc.Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics AwardNASDAQ:NAUTNautilus Biotechnology Inc
01/11/202313h05GlobeNewswire Inc.Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell DevelopmentNASDAQ:NAUTNautilus Biotechnology Inc
31/10/202321h02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NAUTNautilus Biotechnology Inc
31/10/202313h05GlobeNewswire Inc.Nautilus Biotechnology Reports Third Quarter 2023 Financial ResultsNASDAQ:NAUTNautilus Biotechnology Inc
11/10/202314h05GlobeNewswire Inc.Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023NASDAQ:NAUTNautilus Biotechnology Inc
06/09/202313h30GlobeNewswire Inc.Nautilus Biotechnology to Participate in Upcoming September Investor ConferencesNASDAQ:NAUTNautilus Biotechnology Inc
04/08/202314h00GlobeNewswire Inc.Nautilus Biotechnology to Participate in Upcoming August Investor ConferencesNASDAQ:NAUTNautilus Biotechnology Inc
02/08/202322h03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NAUTNautilus Biotechnology Inc
02/08/202313h30GlobeNewswire Inc.Nautilus Biotechnology Reports Second Quarter 2023 Financial ResultsNASDAQ:NAUTNautilus Biotechnology Inc
11/07/202315h23GlobeNewswire Inc.Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023NASDAQ:NAUTNautilus Biotechnology Inc
21/06/202312h03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NAUTNautilus Biotechnology Inc
17/06/202301h53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NAUTNautilus Biotechnology Inc
 Showing the most relevant articles for your search:NASDAQ:NAUT

Kürzlich von Ihnen besucht

GATE
HIDUSDT
Hypersign Identity Token
NASDAQ
TOMZ
TOMI Environmental Solut...
DBI
LJML
INXTMSUS CONDI1C DL
COIN
PSLUST
Pastel
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten